Results

Total Results: 9,462 records

Showing results for "cancer".
Users also searched for: colon cancer screening

261. Archived: Final Modeling Report: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-report/breast-cancer-screening-2009
     November 15, 2009 - Some groups model breast cancer in stages, but 3 (models E, S, and W) use tumor size and tumor growth … Age, estrogen receptor status, and tumor size- or stage-specific treatment have independent effects on … Women with estrogen receptor-negative invasive tumors receive nonhormonal therapy only. … Slow-growing tumors are much more common than fast-growing tumors, and the ratio of slow- to fast-growing … The MISCAN-Fadia continuous tumor growth model for breast cancer.

262. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
     July 08, 2002 - Rationale: The USPSTF found fair evidence that tamoxifen and raloxifene may prevent some breast cancers … that the drug was associated with an approximately 50 percent reduction in the risk for developing new cancers … women enrolled in BCPT, the women in these trials were younger, had more estrogen-receptor-negative cancers … When effective, both raloxifene and tamoxifen were effective only against estrogen receptor-positive tumors … (0.8 cancers/1,000 women taking placebo vs 3.1 cancers/1,000 women taking tamoxifen for a median of

263. CERs Report cover (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
     September 01, 2010 - and the most aggressive breast cancers. … Population- based estimates of the relation between breast cancer risk, tumor subtype, and family … Reactivation of Tumor Suppressor Genes in Breast Cancer by Dietary Supplements As. 2009. 178. 5F32AT004876 … Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature … /ep, et 10531 8 4 and 7 1164 9 exp breast neoplasms/pc, eh 7858 10 exp breast neoplasms/ge 18582

264. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/45731/psn-pdf
     September 29, 2017 - Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis. … Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. … https://psnet.ahrq.gov/issue/breast-cancer-screening-denmark-cohort-study-tumor-size-and-overdiagnosis … increased incidence of nonadvanced tumors and ductal carcinoma in situ; the rate of overdiagnosis was … https://psnet.ahrq.gov/issue/breast-cancer-screening-denmark-cohort-study-tumor-size-and-overdiagnosis

265. Overview of Prostate Cancer Screening Decision Models: A Contextual Review for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/vTHBrY6VuqjoouJvUmtkr4
     May 01, 2018 - treatment of screen-detected tumors. … We used the following keywords: prostate cancer/neoplasms, PSA, mass screening, model, microsimulation … by CISNET as “computer models that operate at the level of individuals or smaller entities such as tumors … on age, PSA, or stage/grade of tumor). … Prostate Cancer Group (SPCG-4) trial, which was not conducted in men with screen-detected cancers.

266. CAHPS Cancer Care Survey: Radiation Therapy (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/rad-eng-cancer-551a.pdf
     October 07, 2016 - CAHPS Cancer Care Survey: Radiation Therapy CAHPS® Cancer Care Survey Version: Radiation Therapy … and shrink tumors. … How long have you been treated at this cancer center for cancer? … When was the last time you received radiation therapy for cancer from this cancer center? … cancer care experience possible Clerks and Receptionists at This Cancer Center 43.

267. Statistical Brief #63: Hospital Stays for Lung Cancer, 2006 (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb63.pdf
     November 01, 2008 - maintenance therapy as a principal diagnosis, including lung cancer, secondary malignancies, maintenance … radiology or chemotherapy, and other cancers. … all cancers, lung cancer had the highest mortality rate—more than colon, breast, and prostate cancers … therapy as a principal diagnosis, including lung cancer (28.0 percent), secondary malignancies (9.8 … percent), radiotherapy or chemotherapy (1.4 percent), and other cancers (1.1 percent)—colon, bladder

268. Inpatient Hospital Stays and Emergency Department Visits Involving Influenza, 2006-2016 (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb253-Influenza-Hospitalizations-ED-Visits-2006-2016.pdf
     January 01, 2016 - Cardiac cancers NEO023 Bone cancer NEO025 Skin cancers - melanoma NEO028 Skin cancers - all other … cancers - peritoneum NEO030 Breast cancer - all other types NEO038 Female reproductive system cancers … Endocrine system cancers - pituitary gland NEO069 Cancer of other sites NEO070 Secondary malignancies … NEO066 Malignant neuroendocrine tumors NEO071 Malignant neoplasm, unspecified NEO057 Hodgkin lymphoma … Myelodysplastic syndrome (MDS) NEO074 Conditions due to neoplasm or the treatment of neoplasm FAC006

269. Screening for Lung Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/gpMtFCtW7cvssqc6wRuogm
     March 01, 2021 - Screening for Lung Cancer 1 www.uspreventiveservicestaskforce.org Clinician Summary of USPSTF … Recommendation Screening for Lung Cancer March 2021 The USPSTF recognizes that clinical decisions involve … The USPSTF has revised the recommended ages and pack-years for lung cancer screening. … If a person decides to be screened, refer them for lung cancer screening with low-dose CT, ideally to … a center with experience and expertise in lung cancer screening.

270. Screening for Colorectal Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/xL4XwcPKXBfTWgY5ouzLzy
     May 01, 2021 - Screening for Colorectal Cancer 1 Clinician Summary of USPSTF Recommendation Screening … A Grade For adults aged 50 to 75 years: Screen all adults aged 50 to 75 years for colorectal cancer … B Grade For adults aged 45 to 49 years: Screen adults aged 45 to 49 years for colorectal cancer. … risk for colorectal cancer (ie, no prior diagnosis of colorectal cancer, adenomatous polyps, or inflammatory … Screen all adults aged 45 to 75 years for colorectal cancer.

271. Archived: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening-january-2016
     January 11, 2016 - Most of the additional cancer detected by these methods are invasive tumors rather than ductal carcinoma … Although adjunctive screening may detect more breast cancer, these cancers may fall into 1 of 3 categories … (that is, cancer with adverse histologic features, such as poorly differentiated tumors and triple-negative … , but the tumor does not go on to behave as expected based on its appearance. … the tumor stops progressing at an early invasive stage.

272. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_disposition-comments.pdf
     May 27, 2010 - treatment of prostate cancer, in addition to brain tumors, including those in children.” … a very large number of patients with similar tumors are randomized. … We have corrected the impression that xerostomia is common in patients with advanced cancers. … a very large number of patients with similar tumors are randomized. … We have corrected the impression that xerostomia is common in patients with advanced cancers.

273. Undiagnosed Vaginal Bleeding | PSNet
     psnet.ahrq.gov/web-mm/undiagnosed-vaginal-bleeding
     July 06, 2022 - Optimizing outcomes from cervical neoplasia involves multiple steps: the patient's ability and willingness … Cervical neoplasia is a slow growing disease, taking 10-30 years to progress from Human Papilloma Virus … (HPV) infection and low grade neoplasia to invasive cancer. … virus or more sensitive screening tests such as the Thin-Prep smear to detect clinically important neoplasia … Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou

274. Why do GDPs fail to recognise oral cancer? The argument for an oral cancer checklist. | PSNet
     psnet.ahrq.gov/issue/why-do-gdps-fail-recognise-oral-cancer-argument-oral-cancer-checklist
     March 13, 2024 - Commentary Why do GDPs fail to recognise oral cancer? … The argument for an oral cancer checklist. Citation Text: Dave B. … Why do GDPs fail to recognise oral cancer? The argument for an oral cancer checklist. … This commentary explores causes for delayed diagnoses of oral cancers in general dental care and recommends … Why do GDPs fail to recognise oral cancer? The argument for an oral cancer checklist.

275. Your Experiences with Cancer
     meps.ahrq.gov/survey_comp/hc_survey/paper_quest/2011/CancerSAQ_En.shtml
     January 01, 2011 - This survey is about the lasting effects of cancer and cancer treatments on the lives of those who … have been diagnosed with cancer. … Cancer History This first section asks about your cancer history. … or a malignancy of any kind?   … your cancer?  

276. Your Experiences with Cancer (pdf file)
     meps.ahrq.gov/survey_comp/hc_survey/paper_quest/2011/CancerSAQ_En.pdf
     January 01, 2011 - Date: 1/31/2013 Your Experiences with Cancer l° This survey is about the lasting effects of cancer … and cancer treatments on the lives of those who have been diagnosed with cancer. … Cancer History t This first section asks about your cancer history. … Have you ever been told by a doctor or other health professional that you had cancer or a malignancy … Are you currently being treated for cancer – that is are you planning or recovering from cancer surgery

277. Overdiagnosis in Prostate Cancer Screening Decision Models: A Contextual Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KT7vaWK_JSDNNvEmUAjN8d
     May 01, 2018 - by CISNET as “computer models that operate at the level of individuals or smaller entities such as tumors … consists of tumor onset, time from tumor onset to diagnosis (i.e., sojourn times), and sensitivity … 3 natural history states (healthy, preclinical, clinical) Does not specify stage or grade of tumor … Sensitivity of screening test in an increasing function of time since tumor onset Mechanism … Lifetime Risk of Overdiagnosis (Overdiagnosed Cancer as a Proportion of Screen-Detected Cancers) by Screening

278. Screening for Bladder Cancer in Adults - Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/C6gCSoknL3qd32EDovsUsh
     November 01, 2004 - screening would be small, at best, for the following reasons: there is fair evidence that many of the cancers … tests—such as microscopic urinalysis, urine dipstick, urine cytology, or such new tests as bladder tumor … antigen (BTA) or nuclear matrix protein (NMP22) immunoassay—can detect bladder cancers that are clinically … Screening for Bladder Cancer in Adults Recommendation Statement U.S. … • Smoking increases the risk for bladder cancer; about 50% of all cases of bladder cancer occur in

279. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49672/psn-pdf
     January 01, 2013 - , a consensus is emerging that follow-up longer than 2 years is required to exclude slowly growing cancers … For sub-solid nodules, which often represent low-grade cancers, the optimal frequency and duration of … Variations in lung cancer risk among smokers. J Natl Cancer Inst. 2003;95:470-478. … The probability of malignancy in solitary pulmonary nodules. … , pulmonary carcinoid tumor http://www.ncbi.nlm.nih.gov/pubmed/16236914 http://www.ncbi.nlm.nih.gov/

280. Future Research Needs Document (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
     October 25, 2010 - and the most aggressive breast cancers. … Population- based estimates of the relation between breast cancer risk, tumor subtype, and family history … Reactivation of Tumor Suppressor Genes in Breast Cancer by Dietary Supplements As. 2009. 178. 5F32AT004876 … Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature … /ep, et 10531 8 4 and 7 1164 9 exp breast neoplasms/pc, eh 7858 10 exp breast neoplasms/ge 18582